|
KMID : 0545120210310101350
|
|
Journal of Microbiology and Biotechnology
2021 Volume.31 No. 10 p.1350 ~ p.1357
|
|
|
Isovitexin Is a Direct Inhibitor of Staphylococcus aureus Coagulase
|
|
Xiang Hua
Yang Panpan
Wang Li
Li Jiaxin
Wang Tiedong
Xue Junze
Wang Dacheng
Ma Hongxia
|
|
|
Abstract
|
|
|
|
Staphylococcus aureus (S. aureus) is a major pathogen that causes human pneumonia, leading to significant morbidity and mortality. S. aureus coagulase (Coa) triggers the polymerization of fibrin by activating host prothrombin, which then converts fibrinogen to fibrin and contributes to S. aureus pathogenesis and persistent infection. In our research, we demonstrate that isovitexin, an active traditional Chinese medicine component, can inhibit the coagulase activity of Coa but does not interfere with the growth of S. aureus. Furthermore, we show through thermal shift and fluorescence quenching assays that isovitexin directly binds to Coa. Dynamic simulation and structure-activity relationship analyses suggest that V191 and P268 are key amino acid residues responsible for the binding of isovitexin to Coa. Taken together, these data indicate that isovitexin is a direct Coa inhibitor and a promising candidate for drug development against S. aureus infection.
|
|
|
KEYWORD
|
|
|
Isovitexin, coagulase, pneumonia, Staphylococcus aureus, inhibitor
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|